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Thoracoscopy has been revived and expanded by recent
improvements in  endoscopic technology.  The enhanced
application and outcome of VATS (video assisted thoracic
surgery) was retrospectively studied.  Between 1992 and
1995, 82 patients underwent diagnostic thoracoscopy or
interventional VATS.  Indications included:  shortness of
breath with nonspecific x-ray abnormality (45%), pul-
monary nodule (25%),  pleural effusion/empyema (21%),
pneumothorax (14%), and hemoptysis, chronic cough or
lung consolidation (5%).  Sixty-six (83%) of the procedures
were completed thoracoscopically.  Eight procedures (10%)
required addition of a utility mini-thoracotomy and 6 pro-
cedures  (7%) were converted to formal thoracotomy.
Specific diagnostic and/or therapeutic applications of VATS
included: inspection; lysis of adhesions; stapling of blebs;
biopsy of  lung, pleura, or mediastinal structures; drainage
and decortication of empyema; mechanical and chemical
pleurodesis; wedge resection; and segmental resection.
Diagnosis was established and/or treatment completed in
95% of cases.  Pathologic diagnoses included: interstitial
pneumonitis (22%), cancer (19%), bullous disease (15%),
cocci nodule (9%), and other (18%).  There were twenty-
two complications (28.9%) and four deaths (4.8%).  All four
deaths were from causes unrelated to the surgery.  The
most common complications were: residual pneumothorax
or hydrothorax (7), failed pleurodesis (3), and prolonged
incisional pain (2).
The advantage of  reduced chest wall and muscle trauma
utilizing VATS as opposed to traditional thoracotomy trans-
lates to less patient discomfort.  The excellent magnified
visualization afforded by VATS offers the opportunity to
successfully conduct diagnostic and therapeutic interven-
tions in the chest with equal or better visibility.  Our find-
ings suggest that the applicability and success of VATS is
greatly expanding and its complication rate is less or, at
worst, comparable to traditional thoracotomy.
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I IN NT TR RO OD DU UC CT TI IO ON N
Less than a decade ago, the introduction of video technol-
ogy and endoscopic staplers revolutionized thoracoscopy,
which was initially introduced as a diagnostic tool early in
the century.  The less invasive nature of thoracoscopy and
associated video-assisted thoracic surgery (VATS) has result-
ed in an altered practice pattern among referring physi-
cians.1 Patients who would previously have been observed
with serial radiographs or subjected to fine needle biopsy
are now referred for VATS.  The rapid acceptance of VATS
by the surgical community was both due to the compelling
advantages of the new technology, and the pressure
imposed on surgeons by equipment manufacturers and
patients alike.2 Our combined experience from three com-
munity teaching hospitals is presented in this report.
M MA AT TE ER RI IA AL LS S   A AN ND D   M ME ET TH HO OD DS S
Between 1992-1995, 82 patients underwent VATS and were
retrospectively reviewed.  Fifty-six were males and 26 were
females. Age ranged between 15-87 years. Fifty-two
patients were older than 60.  Indications for VATS were
shortness of breath (45%); pulmonary nodules (25%);
pleural effusion (21%); spontaneous pneumothorax (14%);
and hemoptysis, chronic cough, and consolidation, collec-
tively (5%).  VATS was used for inspection, lysis of adhe-
sions, biopsy, stapling of blebs, wedge resection, segmen-
tal resection, decortication, drainage of empyema, and
chemical and mechanical pleurodesis.  All procedures were
performed under general anesthesia with a double lumen
endotracheal tube.  The patient is placed in a posterolater-
al thoracotomy position with the side to be explored posi-
tioned up.  The first port is placed in the mid-axillary line
at the 5th-6th intercostal space followed by a second port
in the mid-axillary line at the 2nd-3rd intercostal space.
Two more ports are occasionally placed in line with the
lower port in the anterior and posterior axillary line.  The
port sites can be connected if conversion to formal thora-
cotomy is required.  CO2 insufflation is used if the lung can-
not be collapsed in a timely manner.
JSLS(1997)1:41-44
96-111-Johna.qxd  3/25/06  3:08 PM  Page 1T Ta ab bl le e   1 1. .
Complications
C CO OM MP PL LI IC CA AT TI IO ON NS S
Residual pneumothorax and/or hydrothorax
Failure of pleurodesis
Incisional pain
Anemia
Subcutaneous emphysema
Elevation of the diaphragm
Hemoptysis
Wound infection
Atrial fibrillation
Ventricular fibrillation
Atelectasis
Diaphragmatic perforation
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R RE ES SU UL LT TS S
Sixty-six operations (83%) were completed thoracoscopi-
cally, eight patients (10%) required a utility incision (VATS)
to expedite the procedure and six patients (7%) were con-
verted to formal thoracotomy.  Every patient had a diag-
nostic thoracoscopy with one or more additional proce-
dures.  Thirty-three patients had wedge resection with or
without lysis of adhesions, drainage of pleural effusion,
pleural biopsy, and pleurodesis. Thirty-eight patients
underwent pulmonary, pleural, or mediastinal biopsies
with or without lysis of adhesions, drainage of pleural fluid
and pleurodesis.  Ten patients had lysis of adhesions with
or without drainage of pleural effusion and pleurodesis.
Two patients underwent empyema drainage.
Thoracoscopic lobectomy was completed in one patient for
bronchiectasis, converted in one patient with cancer and in
another patient with gunshot wound due to equipment fail-
ure.  Median operative time was 60 minutes with a range
of 15-240 minutes, compared to 145 minutes and a range
of 50-205 minutes for those converted to formal thoracoto-
my.   Median blood loss was 25 cc. with a range of 25-500
cc. compared to 300 cc. and a range of 25-500 cc. for the
conversions.  Median postoperative stay was three days
with a range of 1-28 days compared to 4.5 days and a range
of (1-22) days for the conversions.  Four patients died in the
hospital, with a mortality of 4.8%.  All deaths were not relat-
ed to the procedure.  One patient died secondary to pneu-
mocystis carnii pneumonia, two patients died of respirato-
ry failure secondary to interstitial pneumonia, and
advanced bullous disease.  The cause of death in the fourth
patient was never identified.  No diagnosis was achieved in
14 patients (17%).  Eleven patients had shortness of breath
with nonspecific radiographic findings requiring ventilatory
support.  Workup with other modalities failed to achieve a
diagnosis.  Biopsies obtained through VATS showed non-
specific inflammatory changes.  In retrospect, these patients
had congestive heart failure that responded to medical ther-
apy.  Two patients had pulmonary nodules and one patient
had a pleural nodule that were wedged out.  Pathology
showed nonspecific inflammatory changes.   Pathologic
diagnoses included: interstitial pneumonitis (22%), cancer
(19%), bullous disease (15%), cocci nodules (9%) and
pneumonia, empyema, carcinoid tumor, mesothelioma,
obliterative bronchiolitis, asbestosis and thymoma, collec-
tively (18%).  Twenty-two patients (28.9%) suffered com-
plications ( (T Ta ab bl le e   1 1) ).
D DI IS SC CU US SS SI IO ON N
Within a relatively short period of time, VATS has become
widely used in the diagnosis and treatment of many tho-
racic conditions.  Its diagnostic accuracy is reported to be
up to 97%.3,4 Although diagnosis was achieved in only 83%
of our cases, the ability to exercise therapeutic measures
raised the number of patients who benefited from the pro-
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cedure to 95%.  In large series, VATS has a mortality of 0.07-
0.5%, a non-fatal complication rate of 4.2-10.9%, and a con-
version rate of 12.4%.5,6 Our complication rate (29%) is
clearly higher, probably secondary to our early work at the
beginning of our learning curve.  Shortness of breath with
nonspecific x-ray changes was the main indication for VATS
followed by solitary pulmonary nodules and pleural effu-
sion, respectively.  The superiority of VATS stems from the
fact that it offers a magnified panoramic view of the
hemithorax and provides the opportunity to lyse adhesions,
drain fluid, take adequate biopsies, and to address con-
comitant pulmonary, pericardial, and mediastinal diseases.7
In addition, it offers  less postoperative pain and early
return to daily activities.8 
Some specific thoracic surgical problems for which VATS is,
or promises to become, the surgical approach of choice
include: pleurodesis, decortication of early empyema, exci-
sion of peripheral solitary pulmonary nodules, manage-
ment of recurrent primary or secondary spontaneous pneu-
mothorax, and stapling of bullae.  Other less common indi-
cations for VATS include: access to anterior thoracic spine,9
diagnosis of diaphragmatic injuries,10 treatment of mediasti-
nal lesions,11 congenital cardiac lesions in pediatric popu-
lation,12,13 and sympathectomy.6 For open lung biopsy,
VATS is safe and effective, but it is more expensive than
limited thoracotomy.14 Twenty percent of patients with
pleural effusion remain without specific diagnosis after tho-
racentesis and closed pleural biopsy.15 In malignant effu-
sions, traditional pleurodesis may lead to patchy adhesions,
loculated fluid and trapped lung.  VATS allows adequate
mobilization of the lung with effective pleurodesis using
either chemical, mechanical with or without limited
pleurectomy,16 or using only parietal pleurectomy.17
Early and intermediate stage empyema can be treated effec-
tively with VATS.  The pleural space can be debrided under
direct vision, the lung evaluated for re-expansion, associat-
ed pathology evaluated, and decortication performed.7
Early VATS avoids the chronic organizing phase of empye-
ma.18,19 Nevertheless, VATS can still be attempted in these
cases as it can direct the proper site for open thoracotomy,
should it fail.19
Although VATS has been successful in excising central pul-
monary nodules,20 it has become the diagnostic procedure
of choice for peripheral nodules (nodules with close attach-
ment to segmental and subsegmental bronchopulmonary
units and/or with distance to visceral pleura less than 10
mm).  Several methods have been used to localize solitary
nodules.  Wires and hooks have their complications.
Staining with methylene blue has been found to be safe,
effective and obviates wire-related complications.19
However, extensive anthracotic pigmentation may interfere
with proper localization.21 A major concern is that both
above-mentioned methods are associated with 33% pneu-
mothorax, and 20% lung hemorrhage.7,19
A tactile sensor for thoracoscopic localization of pulmonary
nodules has been developed.  It can sense the presence of
a nodule within 15 mm of the lesion by a sudden upward
jump in the resonance frequency curve.22 The application
of VATS for excision of solitary nodules is justified by the
fact that many nodules are benign.  Of interest is the fact
that 9% of the solitary pulmonary nodules in our series
were caused by pulmonary coccidiomycosis.  Should the
nodule be malignant, visualizing the presence of extensive
disease may obviate unnecessary thoracotomy.1
VATS is superior to open thoracotomy in managing recur-
rent spontaneous pneumothorax or persistent air leak
(more than 5 days).23 It is more so in primary spontaneous
pneumothorax where the subpleural bullae can be ade-
quately excised, and pleurodesis performed.  An important
benefit is the reduction in postoperative respiratory dys-
function.23-25 In secondary spontaneous pneumothorax,
VATS is less effective due to the patchy pleural adhesions,
and multiple bullae, some of which may be missed leading
to persistent air leak.23 VATS is not superior to transaxil-
lary mini-thoracotomy for apical bullae, but it has the
advantage of providing an access to other lobes that may
not be accessible with open procedure.25, 26
An important area of debate is the application of VATS for
anatomical lung resection.  It is associated with a potential-
ly fatal complication of bleeding.  Anatomical lung excision
may require the development of a fissure, and in the case
of cancer surgery, lymph node dissection may be tedious
and time-consuming.27 Tumor recurrence in the pleural
cavity and at port sites is a known complication after VATS
in spite of the use of sealed bags to remove the specimen.28
The mechanism of tumor implantation remains unclear.
Nevertheless, VATS can still be used in anatomical lung
resection for non-malignant conditions, such as bronchiec-
tasis.29
An evolving indication for VATS is lung reduction surgery.
Traditionally, the surgery is performed on both lungs by
median sternotomy.  Unilateral lung reduction surgery by
VATS has shown comparable, and in some cases lower,
morbidity and mortality with similar improvement in pul-
monary function,30 except for patients with combination of
hypercapnia and reduced single breath diffusing capacity
for carbon monoxide, who constitute a considerable peri-
operative morbidity.31
In conclusion, the advantage of reduced chest wall and
muscle trauma utilizing VATS as opposed to traditional tho-
racotomy translates to less patient discomfort.  The excel-
lent magnified visualization afforded by VATS offers the
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opportunity to successfully conduct diagnostic and thera-
peutic interventions in the chest with equal or better visi-
bility compared to open thoracotomy.  Our findings sug-
gest that the applicability and success of VATS is expanding
and its complication rate is less or, at least, comparable to
traditional thoracotomy.32 
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